Works matching IS 15228517 AND DT 2022 AND VI 24 AND IP 3
Results: 21
Body imaging for newly diagnosed CNS lymphoma: Evaluating the utility of the evaluation.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 492, doi. 10.1093/neuonc/noab305
- By:
- Publication type:
- Article
PLK inhibitors come of age in pediatric brain tumors.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 427, doi. 10.1093/neuonc/noab298
- By:
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 502, doi. 10.1093/neuonc/noac038
- Publication type:
- Article
Reply to Koekkoek et al. concerning SNO and EANO practice guideline update.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 501, doi. 10.1093/neuonc/noac015
- By:
- Publication type:
- Article
Predictors of long-term survival among patients with brain metastases.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 494, doi. 10.1093/neuonc/noab285
- By:
- Publication type:
- Article
Outcomes after first relapse of children with intracranial ependymoma treated on the second l'Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) protocol.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 480, doi. 10.1093/neuonc/noab297
- By:
- Publication type:
- Article
New life for an old therapy: ELTD1 as a downstream target of angiogenesis.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 412, doi. 10.1093/neuonc/noab286
- By:
- Publication type:
- Article
Progressive multifocal leukoencephalopathy after first-line radiotherapy and temozolomide for glioblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 497, doi. 10.1093/neuonc/noab306
- By:
- Publication type:
- Article
Letter regarding "SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors".
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 499, doi. 10.1093/neuonc/noab283
- By:
- Publication type:
- Article
Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 358, doi. 10.1093/neuonc/noab279
- By:
- Publication type:
- Article
Optimizing an effective combination of the new microtubule-targeting agent lisavanbulin with standard-of-care therapy for glioblastoma in patient-derived xenograft preclinical models.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 396, doi. 10.1093/neuonc/noab278
- By:
- Publication type:
- Article
Treat the VTE and worry less about the hemorrhage: A sigh of relief or is the jury still out for therapeutic anticoagulation in high-grade glioma?
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 465, doi. 10.1093/neuonc/noab277
- By:
- Publication type:
- Article
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 331, doi. 10.1093/neuonc/noab262
- By:
- Publication type:
- Article
DNA methylation-based prognostic subtypes of chordoma tumors in tissue and plasma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 442, doi. 10.1093/neuonc/noab235
- By:
- Publication type:
- Article
Body CT and PET/CT detection of extracranial lymphoma in patients with newly diagnosed central nervous system lymphoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 482, doi. 10.1093/neuonc/noab234
- By:
- Publication type:
- Article
EGFRvIII transcriptome in glioblastoma: A meta-omics analysis.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 429, doi. 10.1093/neuonc/noab231
- By:
- Publication type:
- Article
Treatment and outcome of intracranial ependymoma after first relapse in the 2nd AIEOP protocol.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 467, doi. 10.1093/neuonc/noab230
- By:
- Publication type:
- Article
novel PLK1 inhibitor onvansertib effectively sensitizes MYC-driven medulloblastoma to radiotherapy.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 414, doi. 10.1093/neuonc/noab207
- By:
- Publication type:
- Article
Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 455, doi. 10.1093/neuonc/noab198
- By:
- Publication type:
- Article
ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 398, doi. 10.1093/neuonc/noab181
- By:
- Publication type:
- Article
Preclinical modeling in glioblastoma patient-derived xenograft (GBM PDX) xenografts to guide clinical development of lisavanbulin—a novel tumor checkpoint controller targeting microtubules.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 384, doi. 10.1093/neuonc/noab162
- By:
- Publication type:
- Article